Brief: Irras Buys Proprietary Assets
May 7 (Reuters) - Irras AB IRRAS.ST :
* IRRAS STRENGTHENS POSITION IN NEUROCRITICAL CARE BY
ACQUIRING
PROPRIETARY ASSETS, INCLUDING FOUR US FDA-CLEARED PRODUCTS
* ASSETS COMPLEMENT IRRAFLOW AND SUPPORT POSITIONING AS A
LEADING
COMPANY IN SPACE
* SALES OF ACQUIRED PRODUCTS WILL BE INITIATED IN US IN Q3
* TOTAL PURCHASE PRICE FOR ASSETS WAS 700,000 USD.
Source text for Eikon: ID:nWkrRqxpK
Further company coverage: IRRAS.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Irras AB
See all newsBrief: Irras's Says Application For Delisting Has Been Approved
Brief: IR Holding Bidco Says It Requests Compulsory Buy-Out And IRRAS Applies For Delisting
Brief: Irras Extends Maturity Date Of SEK 20 Mln Loan
Brief: Irras Secures Extended Short-Term Loan Agreement
Brief: Irras Sees Risk Of Becoming Insolvent